Modelling of the Time-Varying Pharmacokinetics of Therapeutic Monoclonal Antibodies: A Literature Review
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modelling of the Time-Varying Pharmacokinetics of Therapeutic Monoclonal Antibodies: A Literature Review
Authors
Keywords
-
Journal
CLINICAL PHARMACOKINETICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-26
DOI
10.1007/s40262-019-00816-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetic parameters of infliximab influence the rate of relapse after de-escalation in adults with inflammatory bowel diseases
- (2019) Antoine Petitcollin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Population Pharmacokinetic Modeling of Benralizumab in Adult and Adolescent Patients with Asthma
- (2019) Li Yan et al. CLINICAL PHARMACOKINETICS
- Influence of Antigen Mass on the Pharmacokinetics of Therapeutic Antibodies in Humans
- (2018) David Ternant et al. CLINICAL PHARMACOKINETICS
- Population Pharmacokinetics of Gemtuzumab Ozogamicin in Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia
- (2018) Joanna C. Masters et al. CLINICAL PHARMACOKINETICS
- Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status
- (2018) Paul G. Baverel et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Modeling Immunization To Infliximab in Children With Crohn’s Disease Using Population Pharmacokinetics: A Pilot Study
- (2018) Antoine Petitcollin et al. INFLAMMATORY BOWEL DISEASES
- Explaining Interpatient Variability in Adalimumab Pharmacokinetics in Patients With Crohnʼs Disease
- (2018) Sophie E. Berends et al. THERAPEUTIC DRUG MONITORING
- Population Pharmacokinetic Modeling of Gemtuzumab Ozogamicin in Adult Patients with Acute Myeloid Leukemia
- (2018) Jennifer Hibma et al. CLINICAL PHARMACOKINETICS
- Antibodies to watch in 2019
- (2018) Hélène Kaplon et al. mAbs
- A Real-life Population Pharmacokinetic Study Reveals Factors Associated with Clearance and Immunogenicity of Infliximab in Inflammatory Bowel Disease
- (2017) Johannan F. Brandse et al. INFLAMMATORY BOWEL DISEASES
- Population Pharmacokinetics and Target Engagement of Natalizumab in Patients With Multiple Sclerosis
- (2017) Kumar Kandadi Muralidharan et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall response
- (2017) Hongshan Li et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Model-based clinical pharmacology profiling and exposure-response relationships of the efficacy and biomarker of lebrikizumab in patients with moderate-to-severe asthma
- (2017) Rui Zhu et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study
- (2017) Robert J. Moots et al. PLoS One
- Validation of a Drug-Resistant Anti-Adalimumab Antibody Assay to Monitor Immunogenicity in the Presence of High Concentrations of Adalimumab
- (2016) Sumin Bian et al. AAPS Journal
- Population pharmacokinetics and exposure–response relationship of amatuximab, an anti-mesothelin monoclonal antibody, in patients with malignant pleural mesothelioma and its application in dose selection
- (2016) Anubha Gupta et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis
- (2016) Johannan F. Brandse et al. Clinical Gastroenterology and Hepatology
- Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers and Subjects with Multiple Sclerosis: Analysis of Phase I–III Clinical Trials
- (2016) Lei Diao et al. CLINICAL PHARMACOKINETICS
- Model-based pharmacokinetic analysis of elotuzumab in patients with relapsed/refractory multiple myeloma
- (2016) Leonid Gibiansky et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Target-independent variable region mediated effects on antibody clearance can be FcRn independent
- (2016) Ryan L. Kelly et al. mAbs
- Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges
- (2016) Emilie M.J. van Brummelen et al. ONCOLOGIST
- Population pharmacokinetics of infliximab in patients with inflammatory bowel disease: potential implications for dosing in clinical practice
- (2015) D. J. Buurman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetics of adalimumab in Crohn’s disease
- (2015) David Ternant et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics and Exposure–Efficacy Relationship of Adalimumab in Pediatric Patients with Moderate to Severe Crohnʼs Disease
- (2015) Shringi Sharma et al. INFLAMMATORY BOWEL DISEASES
- Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease
- (2015) Janet R. Wade et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies
- (2015) Amita Datta-Mannan et al. mAbs
- Influence of Immunogenicity on the Efficacy of Long-Term Treatment with TNFαBlockers in Rheumatoid Arthritis and Spondyloarthritis Patients
- (2015) Inesa Arstikyte et al. Biomed Research International
- Immunogenicity of Anti-TNF-α Biotherapies: II. Clinical Relevance of Methods Used for Anti-Drug Antibody Detection
- (2015) Klaus Bendtzen Frontiers in Immunology
- Population Pharmacokinetic Modeling of LY2189102 after Multiple Intravenous and Subcutaneous Administrations
- (2014) Sébastien Bihorel et al. AAPS Journal
- Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease
- (2014) Iris Dotan et al. INFLAMMATORY BOWEL DISEASES
- Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation
- (2013) Pauline A van Schouwenburg et al. ANNALS OF THE RHEUMATIC DISEASES
- The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab
- (2013) Bella Ungar et al. GUT
- Population Pharmacokinetics of Palivizumab, a Humanized Anti-Respiratory Syncytial Virus Monoclonal Antibody, in Adults and Children
- (2012) Gabriel J. Robbie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Immunogenicity of biological therapeutics
- (2012) Charlotte Krieckaert et al. CURRENT OPINION IN RHEUMATOLOGY
- Population Pharmacokinetics of Rituximab in Patients With Chronic Lymphocytic Leukemia
- (2012) Jing Li et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetic Properties of Infliximab in Children and Adults with Crohn's Disease: A Retrospective Analysis of Data from 2 Phase III Clinical Trials
- (2011) Adedigbo A. Fasanmade et al. CLINICAL THERAPEUTICS
- Population pharmacokinetics of golimumab in patients with ankylosing spondylitis: impact of body weight and immunogenicity
- (2011) Z.H. Xu et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Population pharmacokinetics of ustekinumab in patients with active psoriatic arthritis
- (2011) Y.W. Zhu et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Population PK and IgE Pharmacodynamic Analysis of a Fully Human Monoclonal Antibody Against IL4 Receptor
- (2011) Tarundeep Kakkar et al. PHARMACEUTICAL RESEARCH
- Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis
- (2011) D. Pascual-Salcedo et al. RHEUMATOLOGY
- Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Nathanael L. Dirks et al. CLINICAL PHARMACOKINETICS
- Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
- (2009) Adedigbo A. Fasanmade et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Population Pharmacokinetics of Golimumab, an Anti-Tumor Necrosis Factor-α Human Monoclonal Antibody, in Patients With Psoriatic Arthritis
- (2009) Zhenhua Xu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL-12/23p40, in Patients With Moderate to Severe Plaque Psoriasis
- (2009) Yaowei Zhu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Population Pharmacokinetics of Infliximab in Patients With Ankylosing Spondylitis
- (2008) Zhenhua Xu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Interindividual variability in the concentration-effect relationship of antilymphocyte globulins-a possible influence of FcγRIIIa genetic polymorphism
- (2007) David Ternant et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started